BICALUTAMIDE-DRLA bicalutamide 50mg tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

bicalutamide, Quantity: 50 mg

Inapatikana kutoka:

Dr Reddys Laboratories Australia Pty Ltd

INN (Jina la Kimataifa):

Bicalutamide

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; crospovidone; sodium lauryl sulfate; magnesium stearate; titanium dioxide; macrogol 400

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

28 tablets, 30 Tablets

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Treatment of advanced prostate cancer in combination with LHRH agonist therapy. Prevention of disease flare associated with the use of LHRH agonists.

Bidhaa muhtasari:

Visual Identification: White, round, biconvex, immediate release, film coated tablets debossed with R on one side and "573" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2011-06-01

Taarifa za kipeperushi

BICALUTAMIDE-DRLA
_Bicalutamide _
CONSUMER MEDICINE INFORMATION
_ _
WHAT IS IN THIS LEAFLET
This leaflet answers some of the common questions people ask about
Bicalutamide-DRLA. It does
not contain all the information that is known about Bicalutamide-DRLA.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor will have weighed
the risks of you taking
Bicalutamide-DRLA against the benefits they expect it will have for
you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST. KEEP THIS
LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT BICALUTAMIDE-DRLA IS FOR
Bicalutamide-DRLA is used in combination with other medicines to treat
advanced prostate cancer.
Bicalutamide-DRLA is an anti-androgen medicine. Androgens such as
testosterone are natural male
sex hormones. In some types of prostate cancer, androgens may help the
cancer cells to grow.
Bicalutamide-DRLA interferes with some of the actions of these
hormones.
Bicalutamide-DRLA should only be taken by men.
FOLLOW ALL DIRECTIONS GIVEN TO YOU BY YOUR DOCTOR.
They may differ from the information in this leaflet.
Your doctor may prescribe this medicine for another use. Ask your
doctor if you want more information.
Bicalutamide-DRLA is not addictive.
BEFORE YOU USE BICALUTAMIDE-DRLA
_WHEN YOU MUST NOT USE IT _
DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE A WOMAN. Women are not
normally treated with
Bicalutamide-DRLA.
DO NOT GIVE BICALUTAMIDE-DRLA TO CHILDREN. There is no experience of
its use in children.
DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE ALLERGIC TO BICALUTAMIDE OR
ANY OF THE OTHER
INGREDIENTS IN BICALUTAMIDE-DRLA.
DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE TAKING CISAPRIDE OR THE
ANTIHISTAMINES, TERFENADINE
AND ASTEMIZOLE.
DO NOT TAKE BICALUTAMIDE-DRLA AFTER THE USE BY (EXPIRY) DATE PRINTED
ON THE PACK. It may have
no effect at all or an unexpected effect if you take it after the
expiry date.
DO NOT TAKE BICALUTAMIDE-DRLA IF THE PACKAGING IS TORN OR SHOWS SIG